Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/SPL stock hub

ASX/SPL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ASX/SPLis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
303.2M
Australian Securities Exchange
Market data

Live price

Current market quote for this ticker.

Current price
ASX/SPL
In the news

Latest news · ASX/SPL

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 20.4P75 41.2
Trailing P/En/a
P25 14.2P50 19.2P75 35.1
ROE-14.5
P25 -118.7P50 -49.4P75 -1.2
ROIC-8.4
P25 -74.7P50 -33.5P75 0.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ASX/SPL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
185
Groups with data
11
Currency
AUD
Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Australia
Country code
AU
Employees
40
Employees Change
-5%
Employees Change Percent
-11.11
Enterprise value
AUD 285.8M
Exchange
Australian Securities Exchange
Financial currency
AUD
First seen
2026-05-10
Industry
Biotechnology
Isin
AU000000SPL0
Last refreshed
2026-05-10
Market cap
AUD 303.2M
Price
AUD 0.72
Price currency
AUD
Rev Per Employee
364,450x
Sector
Healthcare
Sic
2836
Symbol
asx/SPL
Website
https://starpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-1.07%
EV Earnings
-88.45x
EV/FCF
-259.79x
EV/Sales
19.6x
FCF yield
-0.36%
P/B ratio
14.12x
P/S ratio
20.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

16
MetricValue
EBIT Margin
-22.16%
EBITDA Margin
-20.32%
Gross margin
29.59%
Gross Profit
AUD 4.3M
Net Income
AUD -3.2M
Net Income Growth Quarters
2%
Net Income Growth Years
0%
Pretax Margin
-22.16%
Profit Margin
-22.16%
Profit Per Employee
AUD -80,775
ROA
-7.24
Roa5y
-16.9
ROCE
-14.99
ROE
-14.47
Roe5y
-35.46
ROIC
-8.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

14
MetricValue
Cagr10y
0.43%
Cagr15y
-3.76%
Cagr1y
658.95%
Cagr20y
1.94%
Cagr3y
16.96%
Cagr5y
-16.04%
EPS Growth Quarters
2
EPS Growth Years
0
Revenue Growth
250.6x
Revenue Growth Q
359.62x
Revenue Growth Quarters
2x
Revenue Growth Years
0x
Revenue Growth3 Y
14.33x
Revenue Growth5 Y
27.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
AUD 0.52
Assets
AUD 26.2M
Cash
AUD 18.2M
Current Assets
AUD 24.2M
Current Liabilities
AUD 4.6M
Debt
AUD 790,000
Debt Equity
AUD 0.04
Debt FCF
AUD -0.72
Equity
AUD 21.5M
Liabilities
AUD 4.7M
Long Term Assets
AUD 1.9M
Long Term Liabilities
AUD 76,000
Net Cash
AUD 17.5M
Net Cash By Market Cap
AUD 5.76
Net Cash Growth
-1.93%
Net Debt Equity
AUD -0.81
Tangible Book Value
AUD 21.5M
Tangible Book Value Per Share
AUD 0.05
WACC
8.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
5.26
Inventory Turnover
4.95
Net Working Capital
AUD 2.2M
Quick ratio
4.86
Working Capital
AUD 19.6M
Working Capital Turnover
AUD 0.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-1.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
4.35%
1Y total return
657.9%
200-day SMA
0.36
3Y total return
60%
50-day SMA
0.55
50-day SMA vs 200-day SMA
50over200
5Y total return
-58.26%
All Time High
2.52
All Time High Change
-71.43%
All Time High Date
2021-02-16
All Time Low
0.08
All Time Low Change
778.05%
All Time Low Date
2025-05-21
ATR
0.04
Beta
0.78
Beta1y
2.48
Beta2y
1.12
Ch YTD
100
High
0.73
High52
0.76
High52 Date
2026-05-07
High52ch
-5.26%
Low
0.72
Low52
0.08
Low52 Date
2025-06-23
Low52ch
778.05%
Ma50ch
31.48%
Price vs 200-day SMA
101.01%
RSI
64.38
RSI Monthly
78.59
RSI Weekly
77.11
Sharpe ratio
2.26x
Sortino ratio
5.8
Total Return
-1.07%
Tr YTD
100
Tr15y
-43.75%
Tr1m
41.18%
Tr1w
1.41%
Tr3m
94.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
AUD -3.2M
Operating margin
-22.16

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
320,686,193%
Net Borrowing
-870,000
Shares Insiders
15.63%
Shares Institutions
23.05%
Shares Out
421,149,278
Shares Qo Q
0.17%
Shares Yo Y
1.07%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

54
MetricValue
Adjusted FCF
AUD -2M
Average Volume
2,077,746.6x
Bv Per Share
0.05
CAPEX
AUD -248,000
Ch10y
4.35
Ch15y
-43.75
Ch1m
41.18
Ch1w
1.41
Ch1y
657.9
Ch20y
46.94
Ch3m
94.6
Ch3y
60
Ch5y
-58.26
Ch6m
118.2
Change
-1.37%
Change From Open
-1.37
Close
0.73
Days Gap
0
Depreciation Amortization
269,000
Dollar Volume
558,322.6
Earnings Date
2026-05-18
EBIT
AUD -3.2M
EBITDA
AUD -3M
EPS
AUD -0.01
F Score
4
FCF
AUD -1.1M
FCF EV Yield
-0.38x
FCF Per Share
AUD -0
Financing CF
-870,000
Fiscal Year End
June
Founded
1,997
Investing CF
-248,000
Is Primary Listing
1
Last Earnings Date
2026-02-25
Last Report Date
2025-12-31
Ma150
0.43
Ma150ch
67.17%
Ma20
0.69
Ma20ch
3.85%
Net CF
-2,029,000
Next Earnings Date
2026-05-18
Open
0.73
Position In Range
33.33
Ppne
1,923,000
Price Date
2026-05-08
Ptbv Ratio
14.12
Relative Volume
0.38x
Revenue
14,578,000x
SBC By Revenue
5.97x
Share Based Comp
871,000
Tr20y
46.94%
Tr6m
118.18%
Volume
775,448
Z Score
-3.27
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ASX/SPL pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/SPL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+657.9%
S&P 500 1Y: n/a
3Y total return
+60.0%
S&P 500 3Y: n/a
5Y total return
-58.3%
S&P 500 5Y: n/a
10Y total return
+4.3%
S&P 500 10Y: n/a
Ownership

Who owns ASX/SPL?

Insider, institutional, and short-interest positioning.

Institutional ownership
+23.1%
Share of float held by funds and institutions
Insider ownership
+15.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+1.1%
Negative means the company is buying back shares.
Technical

ASX/SPL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
64.4
Neutral momentum band
Price vs 200-day MA
+101.0%
50/200-day relationship not available
Beta (5Y)
0.78
Less volatile than the market
Sharpe ratio
2.26
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ASX/SPL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/SPL stock rating?

asx/SPL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/SPL analysis?

The full report lives at /stocks/asx/SPL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/SPL?

The latest report frames asx/SPL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/SPL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.